Register now

Poster Sessions

WBC 2026

Poster Sessions

Find the chairpersons assigned to each poster session and the corresponding poster area.

June 25 Poster Sessions
Name of the session Chair 1 Chair 2 Poster Area
BASIC SCIENCE 1 Rosa Faner Ekaterina Dimakou Poster Area 1
BASIC SCIENCE and REGISTRIES Fiona Mosgrove Raja Dhar Poster Area 1
REGISTRIES & TRAILS 1 Yeon-Mok Oh Kevin Winthrop Poster Area 1
Comorbidities, Immunology & Inflammation 1 Patrick Flume Şermin Börekçi Poster Area 1
Cystic Fibrosis and Bronchiectasis 1 Andrea Gramegna Pierre-Régis Burgel Poster Area 2
Management & Organization of clinical service Timothy Aksamit Letizia Morlacchi Poster Area 2
NTM 1 Natalie Lorent Mattia Nigro Poster Area 2
Allied Healthcare & Patients Alfredo Pachas Arietta Spinou Poster Area 2
PCD and Paediatrics 1 Myrofora Goutaki Refiloe Masekela Poster Area 3
PCD and Paediatrics 2 Amelia Shoemark Laura Petrarca Poster Area 3
Treatments Rachel Thomson Pamela J. McShane Poster Area 3
June 26 Poster Sessions
Name of the session Chair 1 Chair 2 Poster Area
BASIC SCIENCE 2 Lucy Morgan Ekaterina Dimakou Poster Area 1
REGISTRIES & TRAILS 2 Yeon-Mok Oh Raja Dhar Poster Area 1
Comorbidities, Immunology & Inflammation 2 Doreen Addrizzo Harris Lucy Burr Poster Area 1
Cystic Fibrosis and Bronchiectasis 2 Andrea Gramegna Şermin Börekçi Poster Area 1
Infections Rachel Thomson Anthony De Soyza Poster Area 2
NTM 2 Charles Daley Kozo Morimoto Poster Area 2
PCD and Paediatrics 3 Merete Long Anne Chang Poster Area 2
Respiratory Physiotherapy and Airway Clearance Paul McCallion Angela Bellofiore Poster Area 3
Additional Poster Session
Name of the session Chair 1 Chair 2 Poster Area
Oral & Rising Star none none Poster Area 3
Poster Numbering

Legend

A Day + Poster Area
B Session
C Poster Number
D1P1.01.01 Day 1, Poster Area 1, Session 01 and Poster Nr 01
D2P3.10.07 Day 2, Poster Area 3, Session 10 and Poster Nr 07
Abstracts

Poster Abstracts

×
Search :
#PresenterABCSessionTitle
1Meyad AlkarniD1P10101BASIC SCIENCE 1Early Insights into Immunological and Transcriptomic Signatures Related to Radiological Severity in Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)
2Braune Anna Z.D1P10102BASIC SCIENCE 1Feasibility and Safety of Outpatient Parenteral Antibiotic Therapy (OPAT) in Adults with Cystic Fibrosis, Bronchiectasis, Primary Ciliary Dyskinesia and NTM Pulmonary Disease – a Single-Center, Retrospective Cohort Study
3Crystal BourkeD1P10103BASIC SCIENCE 1Mucus is hyperconcentrated in children with bronchiectasis compared to healthy children
4Erin CantD1P10104BASIC SCIENCE 1Mucociliary clearance in the lower airways in bronchiectasis: data from the BRILLIANT study
5Raphael EwenD1P10105BASIC SCIENCE 1Evaluation of Serum Azurocidin (AZU-1) as a potential biomarker of disease activity and predictor of exacerbations in adults with bronchiectasis: Data from the German Bronchiectasis Registry PROGNOSIS
6Paola FaverioD1P10106BASIC SCIENCE 1Impact of geographic and climatic variables and environmental athmospheric pollutants on pulmonary NTM infections: an Italian nationwide case-control study
7Laura FawcettD1P10107BASIC SCIENCE 1STAKEHOLDER ACCEPTABILITY OF PATIENT-DERIVED ORGANOIDS FOR PERSONALISED MEDICINE IN CYSTIC FIBROSIS
8Hye Young HongD1P10108BASIC SCIENCE 1Body mass index trajectory and the risk of bronchiectasis exacerbation: An analysis of the KMBARC cohort
9Linda KunzD1P10110BASIC SCIENCE and REGISTRIES SESSIONBronchoalveolar lavage as a diagnostic tool for assessing disease activity in bronchiectasis
10Melissa McDanielD1P10111BASIC SCIENCE and REGISTRIES SESSIONA secreted factor of Pseudomonas aeruginosa rapidly kills non-tuberculous mycobacteria in biofilms in vitro
11Sonja MomchilovikjD1P10112BASIC SCIENCE and REGISTRIES SESSIONClinical and Microbiological Characteristics of Hospitalized Patients with Bronchiectasis – A One-Year Retrospective Analysis in North Macedonia
12Ilgar MustafayevD1P10113BASIC SCIENCE and REGISTRIES SESSIONRelationship between the Severity of the Clinical Course of primary bronchiectasis (BE) and Family and Genetic History
13James D. ChalmersD1P10201BASIC SCIENCE and REGISTRIES SESSIONFlorensocatib (dipeptidyl peptidase-1 inhibitor) Phase I study in healthy Caucasian subjects
14Tamsin ChislettD1P10202BASIC SCIENCE and REGISTRIES SESSIONValidation of a Privacy-Preserving Cough Monitoring Smartwatch Against Human-Annotated Ground Truth in Adults with Chronic Cough: A Decentralized, Real-World Study
15Zhongbo ChenD1P10203BASIC SCIENCE and REGISTRIES SESSIONComparison of High-Flow Humidified Nasal Oxygen Therapy and Non-invasive Ventilation as an Initial Ventilation Strategy in Acute Exacerbation of Bronchiectasis with Mild to Moderate Hypercapnia:Study Protocol
16Zhongbo ChenD1P10204BASIC SCIENCE and REGISTRIES SESSIONEfficacy and Safety of High-Flow Nasal Cannula Oxygen Therapy versus Conventional Oxygen Therapy in Patients with Acute Exacerbation of Bronchiectasis: Study Protocol for a Multicenter, Randomized Controlled Trial
17Raya CohenD1P10207REGISTRIES & TRAILS 1Long term outcomes of patients with Nocardia isolation in respiratory secretions – a retrospective cohort study
18Meg CrisafulliD1P10208REGISTRIES & TRAILS 1The Australian Bronchiectasis Registry: Demographic and Aetiological Characteristics of a National Adult and Paediatric Cohort
19Fabiana CusatiD1P10209REGISTRIES & TRAILS 1Effectiveness of inhaled colistin in bronchiectasis: a real-world analysis from the REPAIR registry.
20Patrick A. FlumeD1P10210REGISTRIES & TRAILS 1Clinical outcome burden in people with bronchiectasis by baseline pulmonary exacerbation frequency: A real-world data analysis
21Lingyun GaoD1P10211REGISTRIES & TRAILS 1Development and Validation of an Inflammation-Nutrition-CT Integrated Risk Score (INCT-RS) for Predicting Progression from Asymptomatic Radiological Bronchiectasis to Clinical Bronchiectasis
22Rebecca HullD1P10212REGISTRIES & TRAILS 1Inhaled Aztreonam lysine to treat chronic Gram-negative infections in patients with bronchiectasis: results from the VITAL-BE trial
23Merete B LongD1P10213REGISTRIES & TRAILS 1Alpha-1 antitrypsin augmentation in people with bronchiectasis and neutrophilic airway inflammation: results from the proof-of-concept BATMAN trial
24Pontus MertschD1P10214REGISTRIES & TRAILS 1InhalEd ColiFin® in adult bRonchiectasis pAtients with new asymptomatic PseuDomonas aerugInosa infeCtion– an open-lAbel, proof of concepT- randomizEd controlled trial (ERADICATE)
25Sayina AbudukeyoumuD1P10301Comorbidities, Immunology & Inflammation 1Development and validation of a prognostic score for ABPA relapse: a retrospective-prospective cohort study
26Ke Li ChowD1P10302Comorbidities, Immunology & Inflammation 1Identification of novel autoantibodies to unlock targeted treatments and diagnostics in idiopathic non-cystic fibrosis bronchiectasis
27Carlos Gallego MolD1P10303Comorbidities, Immunology & Inflammation 1The Progressive Burden of Bronchiectasis: Comparing Quality of Life Outcomes Between Hospitalised and Non-Hospitalised Patients in BronchUK
28Jiahui HeD1P10304Comorbidities, Immunology & Inflammation 1Serum Azurocidin-1 in bronchiectasis: a pilot study exploring clinical associations
29Raksha JainD1P10305Comorbidities, Immunology & Inflammation 1Sex-specific and estrogen modulation of neutrophil function in bronchiectasis with and without cystic fibrosis
30Chrysavgi KostiD1P10306Comorbidities, Immunology & Inflammation 1Phenotyping eosinophilic inflammation spectrum in bronchiectasis: data from a single centre in Greece
31Chaabouni MalekD1P10307Comorbidities, Immunology & Inflammation 1Case Report: Broncholithiasis in a Patient with Bronchiectasis and COPD
32Keshav MangalickD1P10308Comorbidities, Immunology & Inflammation 1Cachexia is associated with Distinct Microbiome Signatures in the Lower Airway of Patients with Bronchiectasis
33Doreen Addrizzo-HarrisD1P20401Cystic Fibrosis and Bronchiectasis 1Efficacy and Safety of Brensocatib in Patients of Asian Race with Non-cystic Fibrosis Bronchiectasis (NCFB): A Subgroup Analysis of the ASPEN Trial
34Doha BENCHAJID1P20402Cystic Fibrosis and Bronchiectasis 1Clinical and Radiological Profile of Cystic Fibrosis Associated Bronchiectasis: A Descriptive Study of 19 Patients in Morocco
35Judy M BradleyD1P20403Cystic Fibrosis and Bronchiectasis 1Unsupervised home spirometry versus supervised clinic spirometry: Analysis of longitudinal participant-level data from the CLEAR trial in patients with bronchiectasis
36Amanda BruntonD1P20404Cystic Fibrosis and Bronchiectasis 1Association of Inhaled Corticosteroid Use and Clinical Outcomes in Patients with Bronchiectasis
37Isaac CohenD1P20405Cystic Fibrosis and Bronchiectasis 1MCCSA2 a Combination of the b- agonist Formoterol and the Cholinergic Agonist Methacholine Induce Synergistic Activation of Mucociliary Clearance in a CFTR Independent Manner
38Annemarie T. EngelD1P20406Cystic Fibrosis and Bronchiectasis 1Pediatric simulations of verducatib (BI 1291583) in adolescents to support Phase III dose selection
39Ashleigh FoubisterD1P20407Cystic Fibrosis and Bronchiectasis 1Impaired B-cell responses to P. aeruginosa and their impact on antibody production in bronchiectasis; a substudy in the EMBARC-BRIDGE cohort
40Rui JiangD1P20408Cystic Fibrosis and Bronchiectasis 1Plasma Proteomic Signatures for Incident Bronchiectasis: Causal Validation, Severity Stratification, and Predictive Modeling
41Anthony de-SoyzaD1P20409Cystic Fibrosis and Bronchiectasis 1BRACE - a multicentre UK audit of multidisciplinary bronchiectasis care
42Jinliang KongD1P20410Cystic Fibrosis and Bronchiectasis 1Navigating Therapeutic Dilemmas: Management of Pseudomonas aeruginosa Pneumonia in a Patient with Severe Immune Thrombocytopenia and Underlying Bronchiectasis—A Case Report
43Mariana LimaD1P20411Cystic Fibrosis and Bronchiectasis 1A rare X-linked cause of bronchiectasis
44Jia hui HeD1P20412Cystic Fibrosis and Bronchiectasis 1Platelet count, clinical outcomes, and antibiotic and anti-inflammatory treatment in adults with bronchiectasis
45Rachel AndersonD1P20501Management & Organization of clinical serviceOptimising paediatric to adult transition clinics for patients with Non-Cystic Fibrosis Bronchiectasis: A thematic analysis of data collected from service users and healthcare professionals
46Lucy BurrD1P20502Management & Organization of clinical serviceRecognising Diffuse Panbronchiolitis in Multicultural Bronchiectasis Populations: The Diagnostic Value of Nasal Nitric Oxide
47Anthony De SoyzaD1P20503Management & Organization of clinical serviceUK Clinician Access, Utilisation and Eligibility Perspectives Genetic testing in Bronchiectasis: A National Survey
48Warnakulasuriya Susanne Nirodhani FernandoD1P20504Management & Organization of clinical serviceKnowledge, Attitudes, and Practices Regarding Clinical Management of Bronchiectasis Among Doctors Managing Adult Respiratory Illnesses in Sri Lanka: A Cross-Sectional Study
49Nikolas JohlD1P20505Management & Organization of clinical serviceDiagnostic Detectives: outcomes from the case files of a regional bronchiectasis diagnostic clinic
50Peter KahnD1P20506Management & Organization of clinical serviceImportance of Understanding the Patient Experience in Healthcare: An Example of the Integrated Patient Journey in Non-Cystic Fibrosis Bronchiectasis
51Peter A KahnD1P20507Management & Organization of clinical serviceCaregiver Perspectives on Pediatric Non-Cystic Fibrosis Bronchiectasis Clinical Trial Design: Insights from US Caregiver Panels
52Rebecca KeatingD1P20508Management & Organization of clinical serviceImproving access to airway clearance devices in bronchiectasis: A service evaluation of Aerobika provision through a Mater Foundation initiative
53Simone TunesiD1P20509Management & Organization of clinical serviceUnity is strength: early results from a joint pulmonology–infectious diseases outpatient clinic for the management of infectious complications of bronchiectasis at the Alessandria University Hospital
54Dong-Woo HanD1P20510Management & Organization of clinical serviceNationwide trends in incidence and management of bronchiectasis in Korea
55Sophia MüllerD1P20601NTM 1Molecular identification and resistance profile of respiratory NTM strains in a single center over a five-year period
56Rosa AndradeD1P20602NTM 1Species Distribution and Geographic Clustering of Nontuberculous Mycobacterial Isolates at UC Irvine Medical Center, 2020–2024
57Chih Jung ChangD1P20603NTM 1Drug Susceptibility Profiles of Clinically Relevant Nontuberculous Mycobacteria in Patients with Bronchiectasis: An Update from a Medical Center
58Hayoung ChoiD1P20604NTM 1Risk of mycobacterial lung disease in lung cancer survivors: A nationwide longitudinal study
59Paola FaverioD1P20605NTM 1High Prevalence of Malnutrition and Sarcopenia in patients with NTM pulmonary disease in a High-Income Country
60Anas HadehD1P20606NTM 1Solitary Pulmonary Nodules in Nontuberculous Mycobacterial Infection: An Underrecognized Presentation in Bronchoscopy Practice
61Eric HouptD1P20607NTM 1Clinical outcomes in a prospective cohort of 105 adults with speciated Mycobacterium avium complex lung disease, 2021-2026
62Hyung-Jun KimD1P20608NTM 1Pulmonary Rehabilitation in Nontuberculous Mycobacterial Pulmonary Disease: A Prospective Cohort Study
63NITYANAND JAIND1P20609NTM 1Operational Constraints Shape Real-World Weighting of NTM-PD Diagnostic Domains in Clinical Decision-Making
64Meg CrisafulliD1P20701Allied Healthcare & PatientsIdentifying international research priorities for bronchiectasis
65Anthony De SoyzaD1P20702Allied Healthcare & PatientsLearning Points from Patient Experiences of Video-Supported Recruitment: A SWAT within the BOAT Trial
66Linda EspositoD1P20703Allied Healthcare & PatientsEarly Real-World Experience with Brinsupri† on Airway Clearance and Clinical Symptoms in Bronchiectasis
67Rebecca KeatingD1P20704Allied Healthcare & PatientsRedefining Bronchiectasis Care: What Patients Experience in a CF-Inspired Multidisciplinary Clinic
68Annemarie LeeD1P20705Allied Healthcare & PatientsPrevalence, clinical effects and treatment options for urinary incontinence in people with bronchiectasis: a systematic review
69Annemarie LeeD1P20706Allied Healthcare & PatientsTelehealth healthcare delivery in adults with bronchiectasis: a systematic review
70Annemarie LeeD1P20707Allied Healthcare & PatientsTelehealth physiotherapy for adults with bronchiectasis: a controlled trial
71Jordan LouieD1P20708Allied Healthcare & PatientsPediatric to adult transition pathway in a PCD Clinic: impacts on patients and their families
72Judy SchlossD1P20709Allied Healthcare & PatientsReal-World Airway Clearance Practices in Bronchiectasis- A Patient Reported Survey
73Emily WardD1P20710Allied Healthcare & PatientsLiving Life with Bronchiectasis: A patient experience survey from the LiveBE study
74Shapaguli AizeziD1P30801PCD and Paediatrics 1Diffuse Bronchiolitis as a Respiratory Phenotype in Chinese Children with Primary Ciliary Dyskinesia: A Clinical and Genetic Study
75Shapaguli AizeziD1P30802PCD and Paediatrics 1Evaluation of Screening Tools and Early Diagnostic Predictors for Primary Ciliary Dyskinesia in Chinese Children
76Doha BENCHAJID1P30803PCD and Paediatrics 1Clinical and Etiological Profile of Bronchiectasis in Morocco
77Doha BenchajiD1P30804PCD and Paediatrics 1From underdiagnosis to genetic confirmation: unveiling Primary Ciliary Dyskinesia in Morocco
78Crystal BourkeD1P30805PCD and Paediatrics 1Longitudinal lung clearance index measurements in children and adolescents with bronchiectasis
79Fernanda GamboaD1P30806PCD and Paediatrics 1One Mutation, Three Lives: Variable Expression of Primary Ciliary Dyskinesia Type 7 in Siblings
80Raphael EwenD1P30807PCD and Paediatrics 1Dupilumab for chronic rhinosinusitis with nasal polyps in adults with primary ciliary dyskinesia: a case series
81Moshe HechingD1P30808PCD and Paediatrics 1Recombinant Human DNase in Primary Ciliary Dyskinesia: A Multi-Center Randomized Controlled Trial Protocol
82Nena KaravasiloglouD1P30809PCD and Paediatrics 1A systematic review of growth-related parameters and nutritional status of patients with primary ciliary dyskinesia (PCD)
83Nena KaravasiloglouD1P30810PCD and Paediatrics 2Nutritional supplement use among people with primary ciliary dyskinesia
84Anna-Lena KatzkeD1P30811PCD and Paediatrics 2Automatic reanalysis of genetic data from patients with Primary Ciliary Dyskinesia
85Eleni KortianouD1P30812PCD and Paediatrics 2Cardiorespiratory responses during the modified Shuttle walk test in children with chronic suppurative lung diseases. Comparisons with healthy, age-matched peers.
86Eleni KortianouD1P30813PCD and Paediatrics 2User satisfaction and co-designing a website for physiotherapy management for children with chronic suppurative lung diseases
87Panagiotis DalamarinisD1P30814PCD and Paediatrics 2Using 6-Minute Walk Test and Chester Step Test for Detecting Exertional Desaturation in Children with Chronic Suppurative Lung Disease: A Pilot Study.
88MINJUN LIAOD1P30815PCD and Paediatrics 2Diagnostic Pitfall in High-Speed Video Analysis of Primary Ciliary Dyskinesia: A TTC12-Related Case with Mixed Ciliary Activity
89Regina MonteiroD1P30817PCD and Paediatrics 2Diagnostic Overlap Between PCD and CFTR Dysfunction: An Unresolved Case with Discordant Findings
90Ezequiel BaranD1P30902TreatmentsReal-World Outcomes of Nebulized Levofloxacin in Chronic Bronchial Infection and Non-Cystic Fibrosis Bronchiectasis: A Comparative Analysis from the INBREATHING Registry
91Robert FlowersD1P30903TreatmentsEarly Real-World Experience With Brensocatib in a Safety-Net Bronchiectasis Cohort
92Jiahui HanD1P30904TreatmentsMulti-Target Mechanisms of Kale as a Dietary Intervention in Bronchiectasis: A Network Pharmacology and Molecular Simulation Study
93Jin Hwa LeeD1P30905TreatmentsImpact of inhaled corticosteroids on survival in patients with bronchiectasis
94Andrade RosaD1P30906TreatmentsIncidence, Timing, and Risk Factors for Hepatotoxicity During First-Line Anti-Tuberculosis Therapy in a Multi-Health-System Real-World Cohort
95Judy SchlossD1P30907TreatmentsInhaled Tranexamic Acid Dosing and Environmental Medication Loss From Three Jet Nebulizer Configurations
96MINH DAO NGOD2P10214BASIC SCIENCE 2Bronchoalveolar oxysterols are associated with disease severity and lung function decline in bronchiectasis
97Leonid RamovD2P10215BASIC SCIENCE 2An incidental finding of infected bronchiectasis in a patient with an Asthma COPD overlap exacerbation a 10-year follow up.
98Leonid RamovD2P10216BASIC SCIENCE 2Rapidly Progressive Cystic Bronchiectasis in Suspected Primary Ciliary Dyskinesia: A Challenging Case with Recurrent Severe Exacerbations (Case Report)
99Ilona RosenboomD2P10217BASIC SCIENCE 2Linking sputum metagenome composition to inflammatory profiles in bronchiectasis: a pilot study
100Peter WARKD2P10218BASIC SCIENCE 2Defining the Role of Dipeptidyl Peptidase-1 in Murine Lung Immune Regulation
101Siobhan SinghD2P10219BASIC SCIENCE 2To challenge or not to challenge? What can we learn from nebulised drug reaction assessment data in non-cystic fibrosis bronchiectasis? A retrospective study.
102Ruth Tal-SingerD2P10220BASIC SCIENCE 2Global Baseline Knowledge of Bronchiectasis: Results from the GAAPP Multilingual Online Interactive Quiz
103Aman TiwariD2P10221BASIC SCIENCE 2Cigarette smoke extract and LPS trigger RIPK1/RIPK3/MLKL-mediated necroptosis and fibrotic lung injury
104Pauline VermoesenD2P10222BASIC SCIENCE 2AIR-BREES: Airway Inhalation Risks—a Bronchiectasis Respiratory Environmental Exposure Survey
105Christine K. WongD2P10223BASIC SCIENCE 2Pseudomonas aeruginosa infection increases sputum viscoelasticity and chronic inflammation in bronchiectasis
106Yingzhou XieD2P10224BASIC SCIENCE 2The response regulator-encoding PA1437 controls antibiotic persistence in Pseudomonas aeruginosa and contributes to recalcitrant chronic infection in bronchiectasis
107B. Shoshana ZhaD2P10225BASIC SCIENCE 2CFTR Function, Modulator Access, and Host-Pathogen Transcriptomics of M. avium in Bronchiectasis and NTM Lung Disease
108Ilgar MustafayevD2P10315REGISTRIES & TRAILS 2Evaluation of Surfactant Therapy in the Treatment of Bronchiectasis
109Lidia PereaD2P10316REGISTRIES & TRAILS 2The frequent exacerbator phenotype in bronchiectasis revisited: Data from the EMBARC registry
110Michal ShteinbergD2P10317REGISTRIES & TRAILS 2Final pooled data from Phase II studies (AIRLEAF®, CLAIRLEAF®) of the dipeptidyl peptidase 1 (or Cathepsin C) inhibitor verducatib in bronchiectasis
111Colin SwensonD2P10318REGISTRIES & TRAILS 2Comparison of Aerobika versus other PEP therapies, in addition to inhaled hypertonic saline, among adult patients in the U.S. Bronchiectasis Research Registry
112Ruth Tal-SingerD2P10319REGISTRIES & TRAILS 2First International Multicenter Validation of the Chronic Airways Assessment Test (CAAT)â„¢ in Bronchiectasis
113Stephanie TheeD2P10320REGISTRIES & TRAILS 2Nocturnal digital cough monitoring in people with Primary Ciliary Dyskinesia and Cystic Fibrosis – First results of an international multi-centre observational study
114Christina ThorntonD2P10321REGISTRIES & TRAILS 2The Impact of Proton Pump Inhibitor (PPI) Use on Exacerbation Rates in Patients with Bronchiectasis: An Analysis of the US Bronchiectasis and NTM Research Registry
115Kazuya ToneD2P10322REGISTRIES & TRAILS 2Induced sputum collection using Lung Flute® ECO in suspected NTM pulmonary disease with bronchiectatic features: a prospective interim analysis
116Claire WainwrightD2P10323REGISTRIES & TRAILS 2Finding the Optimal Regimen for Mycobacterium abscessus Treatment (FORMaT) Trial: First Interim Analysis of 61 Intervention Participants after Short Intensive Therapy
117James D. ChalmersD2P10324REGISTRIES & TRAILS 2Florensocatib, an inhibitor of dipeptidyl peptidase-1, for the treatment of non-cystic fibrosis bronchiectasis: Rationale and Design of the FABLE Phase III trial
118James D. ChalmersD2P10325REGISTRIES & TRAILS 2Subgroup analysis: AIRLEAF® Phase II study of a dipeptidyl peptidase 1 (DPP1, or CatC) inhibitor, verducatib, in adults with non–cystic fibrosis bronchiectasis
119Meret MoormannD2P10409Comorbidities, Immunology & Inflammation 2Serum Club Cell Protein 16 (CC16) and its Association with Bronchiectasis Severity and Activity – Data from the German Bronchiectasis Registry PROGNOSIS
120Craig SchofieldD2P10410Comorbidities, Immunology & Inflammation 2Single-cell RNA sequencing of induced sputum to characterise airway immune cells in paediatric bronchiectasis
121Michal ShteinbergD2P10411Comorbidities, Immunology & Inflammation 2Efficacy and Safety of Brensocatib in Patients With Non-Cystic Fibrosis Bronchiectasis and Comorbid Chronic Rhinosinusitis: A Subgroup Analysis of the ASPEN Trial
122Colin SwensonD2P10412Comorbidities, Immunology & Inflammation 2Efficacy and Safety of Brensocatib in Patients With Non-cystic Fibrosis Bronchiectasis (NCFB) by ROSE Criteria: A Post Hoc Analysis of the ASPEN Trial
123Lynn Te SlaaD2P10413Comorbidities, Immunology & Inflammation 2Bronchiectasis as an underrecognized extra-intestinal manifestation of inflammatory bowel disease
124Rabindra TirouvanziamD2P10414Comorbidities, Immunology & Inflammation 2Sputum metabolomics reveals a shared oxidant signature in non-CF and CF bronchiectasis
125Harm TiddensD2P10415Comorbidities, Immunology & Inflammation 2Bronchiectasis Without Dilatation? How Emphysema Confounds CT Diagnosis
126Aditi LoeweD2P10513Cystic Fibrosis and Bronchiectasis 2Novel Polymeric Reducing Agents as Mucus Modulators in Cystic Fibrosis
127Gabriele MatschinerD2P10514Cystic Fibrosis and Bronchiectasis 2ATL-105, a novel multimodal serine protease inhibitor with immunomodulatory and anti-infective properties for the treatment of non-CF bronchiectasis
128Jia hui HeD2P10515Cystic Fibrosis and Bronchiectasis 2Multidimensional Assessment of the Clinical Evolution of Asthma-Bronchiectasis Overlap
129Jakob RaithD2P10516Cystic Fibrosis and Bronchiectasis 2Clinical implications of traction bronchiectasis in IPF and fibrotic RA-ILD – A retrospective single-center cohort study
130Virginia SantelloD2P10517Cystic Fibrosis and Bronchiectasis 2Oscillometry in the assessment of disease activity and severity in bronchiectasis
131Hisham SaumtallyD2P10518Cystic Fibrosis and Bronchiectasis 2The LTAP-Treated Bronchiectasis Phenotype: Severity, Exacerbation Burden and Microbiological Risk in a Large Tertiary Centre Cohort
132Constance TakawiraD2P10519Cystic Fibrosis and Bronchiectasis 2Patient-focused Target Product Profiles for the development of phage therapies to treat lung infections in cystic fibrosis
133Ruth Tal-SingerD2P10520Cystic Fibrosis and Bronchiectasis 2Patient engagement and collaboration in the design of the Phase III AIRTIVITY® study in people living with bronchiectasis
134Laura TascaD2P10521Cystic Fibrosis and Bronchiectasis 2Compartmentalized PDE3/4 Modulation by Inhaled KIT2014 Improves Airway Epithelial Function and Limits Inflammation in in Non-Cystic Fibrosis Bronchiectasis-relevant models
135Wen-Wen WangD2P10522Cystic Fibrosis and Bronchiectasis 2A Mismatch Between Physiology and Treatment in Bronchiectasis with Airflow Obstruction—Data from BE-China
136Shoshana ZhaD2P10523Cystic Fibrosis and Bronchiectasis 2Characterizing CFTR-Related Disorder Bronchiectasis and Response to Modulator Therapy: A Prospective Multicenter Registry Cohort
137Fengming DingD2P20602InfectionsAssociation of inhaled corticosteroid use and acquiring Pseudomonas aeruginosa in eosinophilic bronchiectasis patients
138Warnakulasuriya Susanne Nirodhani FernandoD2P20603InfectionsBacteriological Profile of Sputum Pyogenic Cultures, Associated Comorbidities, and Complications in Patients with Bronchiectasis Admitted to a Tertiary Care Respiratory Unit in Sri Lanka: A Descriptive Case Series- Preliminary report
139Freddy FrostD2P20604Infections50 shades of green: Longitudinal dynamics of sputum colour and associated clinical outcomes in bronchiectasis
140Espen E GrothD2P20605InfectionsIntra-host Pseudomonas aeruginosa dynamics under antibiotic pressure in COPD and non-CF bronchiectasis: results from an observational trial.
141Moshe HechingD2P20606InfectionsTaking a shot at the future: Impact of vaccination compliance on exacerbations in bronchiectasis patients
142De Sanctis JorgelinaD2P20607InfectionsEvolving Multidrug-Resistant Pseudomonas aeruginosa and Nontuberculous Mycobacterial Infections in Cystic Fibrosis Bronchiectasis Through Bilateral Lung Transplantation
143Nguyen-Ho LamD2P20608InfectionsEtiological and Microbiological Phenotypes of Non-Cystic Fibrosis Bronchiectasis in Vietnam: A High Tuberculosis-Burden Cohort
144Yue SuD2P20609InfectionsAI-Based Risk Prediction of Pseudomonas aeruginosa and NTM Infections in Bronchiectasis Patients Using Chest CT Imaging
145Georg VranaD2P20610InfectionsTreatment Outcomes in Chronic Pulmonary Aspergillosis: A Single-Center Retrospective Analysis
146Zhongbo ChenD2P20710NTM 2The Immune–Metabolic–Pathogen Interaction Network of PD-1⺠T Cell Glycolytic Reprogramming and LAM/Extracellular Vesicles in Non-tuberculous Mycobacterial Pulmonary Disease
147P. MakaniD2P20711NTM 2Quantification of structural lung abnormalities in a cohort bronchiectasis patients with and without Nontuberculous Mycobacteria using the manual BEST-NTM score
148Carla McWilliamsD2P20712NTM 2Nontuberculous Mycobacteria Commonly Detected in Bronchoscopy Patients Without Prior Clinical Suspicion in an Endemic Region
149Hisham SaumtallyD2P20713NTM 2Identifying Vulnerable Patients in NTM PD: Respiratory Comorbidity and Treatment Intolerance Drive Mortality Risk
150Johnny Che I SuD2P20714NTM 2CHARACTERISATION OF ADULT PATIENTS WITH BRONCHIECTASIS AND SPINAL DEFORMITIES
151Harm TiddensD2P20715NTM 2Automatic Mucus Plug Quantification in Bronchiectasis Patients with NTM Infection
152Simone TunesiD2P20716NTM 2Epidemiology and Spatial Distribution of Non-Tuberculous Mycobacteria in a North Italian Region
153Simone TunesiD2P20717NTM 2When a diagnosis doesn’t follow the script: a case report of a M. abscessus pulmonary disease mimicking a rare condition in a bronchiectasic patient
154Sigrid van BrummelenD2P20718NTM 2NTM mapping in the Rotterdam region in the Netherlands
155Cara VarleyD2P20719NTM 2Changes in Complete Blood Count During 12 Months of Treatment for Mycobacterium avium complex Pulmonary Disease: A MAC 2v3 analysis
156James O'HanlonD2P20818PCD and Paediatrics 3A family with primary ciliary dyskinesia (PCD) from pathogenic variants in HYDIN – a case series
157Charlotte O. PiochD2P20819PCD and Paediatrics 3Comparison of cut-off values for nasal nitric oxide measurements in children under four years of age
158Robert ReklowD2P20820PCD and Paediatrics 3An Optimized Immunofluorescence Panel Improves Diagnostic Accuracy for Primary Ciliary Dyskinesia
159Amelia ShoemarkD2P20821PCD and Paediatrics 3Characteristics and outcomes of adults with bronchiectasis due to primary ciliary dyskinesia: combined analysis of EMBARC, Australia, USA and Canadian bronchiectasis registries
160Ben O. StaarD2P20822PCD and Paediatrics 3Integrated Structural, Functional, and Clinical Characterization of NME5 in Primary Ciliary Dyskinesia
161Lea TerbeckD2P20823PCD and Paediatrics 3Establishing Scanning Electron Microscopy for air-liquid interface cultures of individuals with ciliopathies
162Tanya TheriaultD2P20824PCD and Paediatrics 3Implementation of emotional wellness questionnaires in primary ciliary dyskinesia clinic: A social work led quality improvement project
163Dörthe ThüßD2P20825PCD and Paediatrics 3AK8 deficiency causes primary ciliary dyskinesia by disrupting energy homeostasis in the airways
164Dan-hui YangD2P20826PCD and Paediatrics 3In Vitro Gene Therapy Study of Primary Ciliary Dyskinesia Based on DNAI1-mRNA Lipid Nanoparticles
165Martina SantambrogioD2P30102Respiratory Physiotherapy and Airway ClearanceFeasibility and Clinical Utility of Forced Oscillation Technique (FOT) as an Outcome Measure for Airway Clearance Efficacy in Non-Cystic Fibrosis Bronchiectasis: A Pilot Study
166Beatriz Herrero-CortinaD2P30103Allied Healthcare & PatientsInflammation, Cardiac Autonomic Function, and Exercise Capacity in Bronchiectasis: Exploring Interrelated Mechanisms
167Rhiannon JonesD2P30104Respiratory Physiotherapy and Airway ClearancePhysiotherapy Support Staff in Airway Clearance: A Competency‑Led Approach
168Eleni KortianouD2P30105Respiratory Physiotherapy and Airway ClearanceAssociation Between Airway Clearance Technique Adherence and Exacerbation Risk in Children and Adolescents With Non-Cystic Fibrosis Bronchiectasis: A Retrospective Cohort Study
169Yang LiuD2P30106Respiratory Physiotherapy and Airway ClearanceAirway clearance management for bronchiectasis in China: a multicentre cross-sectional study from the Chinese Bronchiectasis Registry (BE-China)
170Bei MaoD2P30107Respiratory Physiotherapy and Airway ClearanceAirway Clearance Technique of Oscillation and Lung Expansion in Bronchiectasis with exacerbation: a multicenter randomized controlled clinical trial
171Helper NirD2P30108Respiratory Physiotherapy and Airway ClearanceMechanical insufflator exsufflation as means for airway clearance in children with non CF- bronchiectasis – a case report
172Erick OumaD2P30109Respiratory Physiotherapy and Airway ClearanceEffectiveness of mucolytic-assisted respiratory physiotherapy in optimizing airway clearance among patients with chronic bronchiectasis: A case report in Nairobi, Kenya.
173Pontus MERTSCHD2P30110Respiratory Physiotherapy and Airway ClearanceReal‑World evidence of Simeox airway clearance device in Muco‑Obstructive Lung Diseases: Results of the German Prospective Multicenter IMPROVE Study
174Martina SantambrogioD2P30111Respiratory Physiotherapy and Airway ClearancePelvic Floor Dysfunctions in Non-CF Bronchiectasis: A Pilot Study
175Sivagurunathan SutharsanD2P30112Respiratory Physiotherapy and Airway ClearanceAn Investigation into Different Oscillating Positive Expiratory Pressure (OPEP) Devices, Assessing Laboratory Metrics Relevant to Performance
We use cookies to ensure that we give you the best experience on our website.We use cookies to improve analyze its performance. You can authorize or block the cookies by clicking the checkbox on the right side of each single cookie. See our cookies policy.
Google Analytics, I accept: